📰 Breaking News: Lessons Learnt & Insights from UK’s first and to date only SME Restructuring Plan

Notices to creditors (MVL)

Amryt Pharma (UK) Limited members' voluntary liquidation

active Company no. 10463152 Published 20 July 2026

In short: Amryt Pharma (UK) Limited (company no. 10463152) entered members' voluntary liquidation, a solvent and planned closure, according to a Notices to creditors (MVL) notice published in The London Gazette on 20 July 2026. The office holders are James Hawksworth (IP No. 22450); Terence Guy Jackson (IP No. 16450), appointed 9 July 2026.

The notice informs creditors of AMRYT PHARMA (UK) LIMITED that, as part of its voluntary winding‑up, they must submit proofs of debt by 14 August 2026 to the joint liquidators.

Notice details

Company
AMRYT PHARMA (UK) LIMITED
Company number
10463152
Registered office
C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
Principal trading address
C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
Type of liquidation
Voluntary winding up (MVL)
Date of appointment
9 July 2026
Office holder(s)/Liquidator(s)
James Hawksworth (IP No. 22450); Terence Guy Jackson (IP No. 16450)
Contact
Harry Short, RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London EC4A 4AB, Tel: 020 3201 8000, Email: [email protected]

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

What happens next

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

All notices for Amryt Pharma (UK) Limited

3 Gazette notices on record for company no. 10463152, newest first. The full history, with last filed accounts, is on the Amryt Pharma (UK) Limited company record.

  1. Appointment of liquidators (MVL) 20 Jul 2026
  2. Resolution for winding up (MVL) 20 Jul 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Amryt Pharma (UK) Limited in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Notices to creditors (MVL) for Amryt Pharma (UK) Limited (company no. 10463152) on 20 July 2026.

What does a Notices to creditors (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

What happens next?

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Who is dealing with the liquidation?

The office holders named in the notice: James Hawksworth (IP No. 22450); Terence Guy Jackson (IP No. 16450), appointed 9 July 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.